Proteases in The Schistosome Life Cycle: A Paradigm For Tumour Metastasis
Proteases in The Schistosome Life Cycle: A Paradigm For Tumour Metastasis
Proteases in The Schistosome Life Cycle: A Paradigm For Tumour Metastasis
Summary
Cancers and parasites have a number of properties in common, particularly those that relate to their
respective capacities to evade host defence mechanisms. This review highlights the similarities between
metastatic tumours and schistosomes in particular, and describes the role that proteases may have in the
migration, growth, survival and transmission of the different stages of the schistosome life-cycle in the
vertebrate host. An elastase-like serine protease of schistosome larvae has been particularly well character-
ized, and its substrate profile and other properties are indicative of a role in facilitating migration of the
parasite through skin tissue early after infection. The primary structures of a cathepsin B-like enzyme, and a
putative 'haemoglobinase' found in adult worms have also recently been derived, these enzymes being
responsible for degradation of haemoglobin in erythrocytes upon which the adults feed. Adult schistosome
worms reside and produce eggs intravascularly, and the processes that mediate the extravasation and
subsequent migration of the egg through host tissue are dependent on both blood platelets and the immune
response. Fibrino(geno)lytic enzymatic activity that is present in the egg could modulate the thrombogenic
potential that eggs might have as a result of their capacity to cause platelet aggregation in vitro and in vivo.
The roles of other proteases and peptidases that have been found in schistosome larvae, worms and eggs are
less clear. Some of these enzymes may modulate immunological and haemostatic defence mechanisms and
thus prolong survival of the parasite, and the consequences of the interactions between schistosomes and
host protease inhibitors could also be immune modulatory.
and transmission of parasites: it is our hope that Points of similarity between schistosomes and
this description of the role of proteases in the schis- metastasizing tumours
tosome life-cycle might in return be of some in-
terest to oncologists. Table i lists on the left side a n u m b e r of steps which
m a n y reviewers agree have to occur during tumour
growth and metastasis. On the right of the Table is
The schistosome life-cycle an indication of stages of the schistosome life-cycle
which seem to have an equivalent hurdle to over-
Schistosomiasis is a disease caused by digenetic come. There follows a consideration of the role
383
that proteases may have in facilitating the migra- nin, Type IV collagen [14], elastin [12], and the
tion and growth of schistosomes at each stage of the peptide backbone of proteoglycans [15], is consis-
life-cycle in definitive hosts. tent with it having a critical role in skin invasion.
Synthesis of the cercarial protease is limited to a
period when cercariae are still developing in the
An elastase-like enzyme involved in skin snail, and the protein is produced as a proenzyme
penetration of schistosome larvae with a structure that allows for a post-translational
modification typical of vertebrate coagulation and
Penetration and migration of schistosome larvae digestive proteases [16}. It has an amino acid se-
through the skin of their vertebrate hosts has for a quence related to that of the trypsin family of serine
long time been considered to be mediated by a proteases, and a particularly high degree of consen-
combination of secreted hydrolytic enzymes and sus with rat pancreatic elastases I and II [16]. Sub-
larval muscular activity. The penetration response strate and inhibitor profiling indicated, however,
of cercariae is chemically stimulated, particularly that aromatic amino acids were preferred at the P-1
by skin lipids, and during entry the larvae lose their site of substrates, suggesting an analogy with chy-
tails and a carbohydrate-rich glycocalyx coat. They motrypsin [12]. The enzyme has a pI of 8, a pH
undergo other morphological and physiological optimum of 9, and its activity is calcium-depend-
transformations, one of which tolerizes them to ent. It is immunogenic, with IgM and IgG antibod-
isotonic conditions [6-8]. Larvae which successful- ies found in infected patients, and its potential
ly enter the skin reach the base of the epidermis usefulness as a diagnostic aid has been considered
within 30 minutes, and they remain epidermal for [17]. A 17 kDa form of the enzyme also occurs,
40 to 48 hours before beginning to enter the dermis perhaps as a result of autoproteolysis [12].
[9, 10]. Assays for proteolytic activity indicated that re-
Early work (reviewed in [6]) indicated that pro- lease of the acetabular gland protease occurred
teolytic enzyme activity secreted from the acetab- over the first 24 hours after cercariae were trans-
ular glands of schistosome cercariae was involved formed into schistosomula [18]. The comparative
in skin penetration. The acetabular glands are con- lengths of time spent by the parasite in the epider-
nected to the apical surface of the parasite by ducts, mis compared with the dermis suggest that the
and the glands empty during the first stages of entry basement membrane may be a substantial barrier
into the skin. A serine protease(s) of Mr 25-30 kDa to progress of the larvae through skin, and electron
has been purified from cercarial extracts [11], and microscopic evidence suggests the acetabular
from skin lipid-induced cercarial secretions [12]. glands are in fact empty of contents prior to breach-
The wide range of substrates hydrolyzed by this ing of the membrane [19]. To what extent lytic
enzyme, including keratin [13], fibronectin, lami- agents other than the cercarial elastase subsequent-
Table 1. Some similarities between metastatic tumours and stages of the schistosome life cycle
Tumours Schistosomes
ly facilitate larval migration remains to be deter- nent of complement [29]. The inhibitory effect of
mined: serine proteases of 60 kDa and 28 kDa have glucocorticoids on schistosome survival and matu-
been identified in secretions of newly transformed ration [30] is further indirect evidence for an in-
schistosomula [20], and metalloproteinase activity flammatory response potentiating larval migra-
is also evident after exhaustion of acetabular gland tion. Cercariae are themselves capable of synthe-
proteolytic activity [18, 21]. sizing eicosanoids [31], perhaps for the same rea-
The importance of proteolytic secretions in the son. In this context it should also be mentioned that
skin invasion phase of schistosome infections larval proteases are known to react with alpha 1-
seems clear, and has been further substantiated by proteinase inhibitor [32, 33], and product(s) of the
the demonstration that a synthetic peptide inhib- interaction between proteases and serine protease
itor of the cercarial elastase, which had no effect on inhibitors are chemotactic for neutrophils [34].
cercarial mobility, prevented cercariae from invad- By virtue of its antigenicity the cercarial elastase
ing human skin explants [22]. In the context of the is a potential target for immune attack, and an IgM
anti-cancer effects of protease inhibitors [23], it monoclonal antibody raised against it inhibited
would be of interest to determine whether the com- proteolytic activity and had complement-depend-
pound niclosamide, which is being promoted as a ent cytotoxicity for cercariae [35]. Contrariwise,
prophylactic against cercarial penetration [24], has we have found that immunoglobulin G is subject to
any effect as a protease inhibitor. degradation by larval extracts. Figure 2 demon-
strates the capacity of a crude S. mansoni cercarial
extract, and a protease in a partially-purified frac-
Immune modulation by larval proteases tion therefrom, to hydrolyze radiolabelled immu-
noglobulin. The hydrolytic activity was inhibited
In addition to a direct effect of hydrolysis of the by heat, preincubation of the extract with diisopro-
extracellular matrix during migration through skin, pylfluorophosphate (DFP), and by pre-absorption
larval proteases could facilitate survival of the par- with a monospecific antiserum raised against a lar-
asite by other indirect means, including modula- val antigen with proteolytic activity. The seemingly
tion of immune effector mechanisms. The cercarial potent hydrolytic activity of this enzyme against
carbohydrate-rich glycocalyx is a strong activator IgG in fact made it difficult for us initially to dem-
of the alternative pathway of complement [25], and onstrate convincingly that serum from immunized
the hydrolytic activities of acetabular gland secre- rabbits contained antibody which could react spe-
tions [26, 27], and particularly of serine proteases cifically with the enzyme. Immunoelectro-phoretic
[20], are believed to mediate in glycocalyx loss evidence of the presence of specific antibody in
during transformation of cercariae to schistosom- such sera was seen only after the enzyme had been
ula. Loss of the glycocalyx could largely explain the pretreated with a serine protease inhibitor (Curtis
increasing resistance of schistosomula to in vitro and Doenhoff, unpublished).
and in vivo killing by complement [25, 27]. Com- IgG that is bound to the schistosomula surface
plement components appear also to be inactivated via Fc receptors is also cleaved off by proteolytic
directly as a result of their hydrolysis by secreted activity [21], and threonine-lysine-proline, a tri-
serine proteases [20]. peptide cleavage product of IgG hydrolyzed by
The vasodilation, margination of leukocytes and excreted products of schistosomula, has been
dermal inflammatory infiltrates which occur within shown to inhibit the toxic effects of macrophages
24 hours of infection [9, 28] may be generated by on schistosomula in an antibody(IgE)-dependent
anaphylactic products of schistosome-induced cytotoxicity reaction [36], and to potentiate IgE
complement degradation. That this could be im- synthesis [37].
portant in facilitating larval migration and growth
is indicated by the smaller worm burdens and short-
er worm lengths in mice deficient in the C5 compo-
385
Fig. 2. Cleavage of human lgG by S. mansoni cercarial protease(s). Purified human IgG, 0.5 mg (Dako Corporation, California), was
labelled with 1z51by the iodogen method as described in reference 75. The radiolabelled product was separated from free isotope by
Sephadex G-50 chromatography, and preliminary analysis of the labelled preparation by sodium dodecyl sulphate- polyacrylamide gel
electrophoresis (SDS-PAGE) under reducing conditions and autoradiography indicated the presence of low molecular weight
degradation products. Intact 1251was obtained as described in reference 76 by subjecting the preparation to SDS-PAGE on 12.5% gels.
After washing the gels a 1 cm wide band containing a single radioactive band of high molecular weight, presumed to be intact IgG, was
excised and a 1 cm square slab was incubated at 37° with 100/zl phosphate buffered saline (PBS), pH 7.6, containing 16/~g (bovine serum
albumin (BSA) protein equivalent) of soluble extract of homogenized S. mansoni cercariae (prepared as in reference [71]). At
successive time intervals between 2 minutes and 10 hours samples of 10 ul were withdrawn from the incubation mixture and the enzyme
activity in these samples was terminated by boiling. The samples were analyzed in SDS-PAGE, followed by autoradiography to
determine the distribution of radiolabel, and panel A shows the results of the incubation time course, as well as, in the first lane, the
product of a control incubation containing labelled IgG without cerearial homogenate. Lane B indicates the result of incubating
radiolabelled IgG for 18 hours at 37° with a 28 kDa diisopropylfluorophosphate(DFP)-binding cercarial protease (40 p.g in 100/zl
incubate), the protease having been partially purified by preparative electrophoresis. In panel C the cercarial homogenate had been
treated with DFP at concentrations of 1.5 x 10-5 mM (left lane) and 3 x 10-5 mM (right lane), before incubation with labelled IgG. In
lane D the cercarial homogenate had been heat-inactivated prior to incubation with labelled IgG, and in lane E prior to incubation with
the labelled IgG the cercarial homogenate had been immunoabsorbed with a rabbit antiserum that had monospecific reactivity against
the 28 kDa cercarial protease.
immediate reaction of blood platelets might be ex- diameter from 15-25/~m when they first arrive, to a
pected upon breach of endothelium integrity, the minimum diameter of about 8 ~m. This, together
platelet activity being directed towards either dam- with muscular exertion by the parasite, is presumed
aged subendothelial matrix or the intruding para- to facilitate migration along the lumena of lung
site, or both. That platelet activity might be delete- capillaries.
rious to the parasite at this stage is indicated by the The fit is tight, however, since although the mini-
observation that mice depleted of platelets by in- mum diameter of the larval worm reduces to 8-
jections of antiplatelet serum at the time of in- 10/~m, this is still up to twice as great as the internal
fection have been found to have worm burdens bore of lung capillaries. Thus, despite the changes
increased by 30 to 45% when compared with un- which the parasites undergo in respect of extensi-
treated controls [38]. It should be noted that typ- bility, the pulmonary microvasculature would
ically only 30 to 50% of S. mansoni cercariae that seem to provide a major mechanical barrier to their
are applied percutaneously to mice mature into free movement throughout the circulation, and
adult worms resident in the hepatic portal system. hence the prolonged lung transit time of 30 hours or
The factors contributing to non-survival of parasit- more, and the retrievability of schistosomula from
es, and the sites where such losses take place are the minced lungs of infected laboratory rodents for
topics still under debate, but this attrition would up to about a week after infection. Migrating larvae
seem to occur after entry into the systemic circula- can cause endothelial damage in the lungs [40].
tion [8]. There is no apparent inflammatory activity asso-
ciated with parasites that are intravascular in the
lung, but some larvae may escape the vascular sys-
Migration and survival of larvae within the vascular tem and induce inflammatory reactions in the alve-
system oli. It is assumed that many of these ectopic parasit-
es fail to survive, but some have the capacity to
Once within the vascular system surviving schisto- re-enter the circulation, as indicated by experi-
some worms remain there for the remainder of ments showing that 12-15% of schistosomula taken
their lives in the definitive host. Work in laboratory from the lungs of donor mice and introduced into
rodents has indicated that in the few days sub- the alveoli of naive mice survived to mature in the
sequent to intravascularization there is a systemic hepatic portal vein of the recipients [41]. It remains
phase of migration of schistosomula in the direc- to be determined whether larval migration through
tion of blood flow, with an estimated mean of 30-35 lung parenchyma is protease-dependent in the
hours required for each of them to transit through same way as migration through skin.
lungs, 16 hours through non-splanchnic systemic Although some tissue damage is caused by pas-
organs and 6.5 hours through splanchnic organs sage of larvae through lungs of infected mice, con-
[8]. During this period there is reasonable agree- siderably more damage in the form of haemorrhag-
ment between total parasite numbers recorded in ic loci is evident around larvae killed in the lungs by
different systemic organs and published values for the schistosomicidal drug praziquantel [42]. That
the fractional distribution of cardiac blood output. proteases, perhaps those released from damaged
Schistosomula of S. mansoni are first found in parasites, are implicated in this is indicated by the
the lungs of laboratory rodents 3 days after in- inhibition of the haemorrhaging by administration
fection, and numbers rise to a peak on days 5 or 6 of aprotonin simultaneously with praziquantel.
[39]. Numbers of larvae recovered from the lungs
then decrease, but some can still be detected in this
tissue as late as 20 days after infection. After first The maturation of schistosome worms
arriving in the lungs the schistosomula undergo a
further physiological change which allows them Concomitant with the decline in numbers of schis-
great changes in extensibility, and a reduction in tosome larvae in the lungs of infected mice there is
387
an increase in the number that can be recovered Protease inhibitors and schistosome w o r m survival
from the liver. The first ones are obtainable by
perfusion of the hepatic portal system on about day One feature that is remarkable about this parasite
7 after infection, and the numbers increase to reach is its capacity to survive for long periods in the
a plateau after about 3 weeks. The factors which intravascular milieu. In mice schistosomes survive
are responsible for entrapment of immature schis- for a year at least [52], and the average life-span for
tosome in the microvasculature of the liver are S. mansoni in humans is estimated at between 5 and
obscure: the proportion of parasites which survive 10 years [53], with cases of infections lasting for 3 or
into adulthood in the hepatic portal system (30- 4 decades having been recorded.
50% of the percutaneously-administered cerca- The mechanisms by which schistosomes evade
riae) could just be a stochastic reflection of the the immune response and prolong their survival
proportion of cardiac output which flows through have received a great deal of attention (see [54] for
that blood system. review). Antigenic disguise of schistosomes by ac-
At this stage of their life-cycle the worms short- quisition or mimicry of host molecules is a mecha-
en, lose motility, and begin to feed on blood and to nism for which considerable evidence existS, and
grow. As they grow they migrate upstream through the finding of alpha 2-macroglobulin (A2M) on the
the portal blood system where four to five weeks surface of adult worms was one of the earlier obser-
after infection males and females begin to pair up. vations of this genre [55], made before the pro-
Maturing schistosomes begin to feed on host eryth- tease-inhibitory function of this macroglobulin was
rocytes, and considerable effort has gone into the fully understood.
characterization of worm acidic proteinase(s) that The nature of the interaction between A2M and
were first described in 1959 [43] and which degrade the parasite surface deserves further investigation,
haemoglobin. particularly to characterize the nature of the para-
The nucleotide sequences of two molecules have site receptor for A2M, and to determine whether
recently been deduced, one having good consensus the inhibitor is taken up by the worm in native form
with human cathepsin B, and the other being that or after complexing with proteases; for example
of a putative schistosome 'haemoglobinase' that enzymes of the complement or blood coagulation
surprisingly has no obvious primary structure simi- cascades, (or does it form complexes with schisto-
larity with known protease families [44, 45]. In some proteases on the worm surface?) A2M can
vitro translation studies on the cathepsin B-like also interact with a wide variety of other molecules,
enzyme indicate that a 37kDa non-glycosylated and its immunomodulatory effects [56] in partic-
prepro-enzyme translation product can carry out ular may be of critical importance in the context of
its own processing to give a proteolytically active facilitating parasite survival.
28 kDa molecule [46]. The worm acid proteases are Contrapsin, a serine protease inhibitor (serpin)
highly immunogenic, and in purified form can in- of mice has also been found associated with adult S.
duce hypersensitivity reactions in infected patients mansoni worms [57]. It has been suggested that the
[47], and may be of use for diagnosis of schistoso- remarkably high rate of mutation in the active site
miasis [48]. regions of serpins is due to the selection pressure
Other adult worm proteases have been identified exerted by continuous exposure to proteases of
and partially characterized, including a gelatinase infectious agents [58], and further detailed study of
excreted by intact male worms [49], dipeptidylami- the nature of the interaction between the proteases
nopeptidases I and II [50], and leucine amino pepti- of the parasite and host protease inhibitors is war-
dases [51]. The specific role of these various en- ranted.
zymes in prolonging the intravascular survival of
schistosomes remains to be determined.
388
Transmission of schistosomiasis: extravasation and could serve physically to lodge the eggs in the me-
excretion of eggs senteric capillaries at sites where they are laid by
the female worms, and thus prevent their being
Egg production by female schistosome worms com- swept away by the blood stream. It has recently
mences in the mesenteric veins (S. mansoni and S. been found that platelet release products promote
japonicum) or the vesical plexus (S. haematobi- the adherence of S. mansoni eggs to cultured hu-
urn). The adult worm pairs are permanently in man umbilical vein endothelial cells in vitro (Ngai-
copula, the female being held in the gynecophoric za, Doenhoff & Jaffe, in preparation), and if this
canal, or schist, of the male, and they remain in- occurs also in vivo it may be another factor which
travascular. The eggs are laid intravascularly and it prevents dissipation of eggs away from the site of
is therefore not surprising that many are carried their initial deposition. The platelet-rich aggre-
away from the site of deposition by blood flow, to gates which form around eggs while they are still in
become lodged in the nearest capillary bed down- the mesenteric capillaries of mice may also in some
stream. A proportion are, however, extravasated way be wholly or partly responsible for actual ex-
and t~averse the intestine or bladder walls to be travasation of the egg [63, 64].
excreted with, respectively, faeces or urine. On Immunosuppressed infected mice fail to excrete
reaching water the eggs hatch into miracidia which schistosome eggs, and excretion rates can be re-
infect snails. stored by reconstitution of such animals with anti-
The excretion of viable eggs from the definitive bodies [71, 72] or immune lymphocytes [64, 65]. It
host is critical to the continuation of the schisto- is not yet clear how or where (intra- or extra-vascu-
some life-cycle. Proteolytic enzymes, together with larly, or both?) acquired immunological effectors
muscular contractions of host tissues, have tradi- mediate their effects on egg excretion. There is a
tionally been considered important mediators in numerical correlation between the number of eggs
the egg excretion process, and collagenolytic [59], excreted and the degree of immunological inflam-
thiol proteinase [60] and leucine aminopeptidolytic matory reactivity generated against tissue-bound
activities [51, 61] have been found in eggs or egg eggs in individual animals [64, 65], and Damian
extracts. The role of most of these enzymes in [66] suggested that the immune granulomas with
parasite survival has not been established, though which eggs in host tissue become surrounded are
the leucine aminopeptidase has been implicated in responsible for 'translocation' of eggs through tis-
the hatching of eggs by virtue of its activity being sue. The exact means by which endothelial integri-
inhibited by high salt concentrations [62]. ty is ruptured and the eggs are transported to the
lumen of the intestine (or of the bladder in the case
of S. haematobium) thus still need clarification.
Platelets and immune effector mechanisms in egg
excretion
Fibrino(geno)lytic schistosome egg proteases
Schistosome egg excretion has latterly been shown
to be additionally dependent on blood platelet ac- The action of one or more egg proteases may be
tivity [63], and on the immune response of the host involved in extravasation of eggs, and the protec-
[64-66]. The connection with tumour metastasis is tion they would require against inactivation by cir-
clear, since both platelets and immune effector culating protease inhibitors may be provided by
mechanisms have also from time to time been im- close aposition between host cells and the egg sur-
plicated in the extravasation of metastatic cells [67- face [73]. The potent platelet aggregating activity
70]. of S. mansoni eggs seems at variance with the ab-
S. mansoni eggs have a potent platelet aggregat- sence of overt thrombotic activity during the course
ing effect both in vitro and in vivo [63]: this reaction of schistosome infections, and one explanation for
389
Fig. 3. Hydrolysis offibrinogen by S. raansoni eggproteases. Panel A: In an adaptation of the method described in reference 77, 10/~1of
soluble extract of S. mansoni eggs, prepared as in reference 71, and containing 120/xg of protein (BSA equivalent) was electrophoresed
under non-reducing conditions in 12.5% SDS-PAGE in which 5 mg human fibrinogen (Kabivitrum, Sweden) had been incorporated per
5 ml gel. After electrophoresis the gel was washed overnight at 37° with PBS, pH 7.6, containing 2.5% Triton X-100 in order to remove
SDS. Proteolytic activity is detectable as clear bands after staining of unhydrolyzed protein in the gel with Coomassie blue.
Panel B: Equal volumes of human fibrinogen (10 mg/ml) and soluble extract of S. mansoni eggs (12 mg/ml) were incubated at 37° in
PBS at pH 7.6. At various intervals 20 ~1 of the incubation mixture were withdrawn and the reaction in these aliquots was terminated by
heat inactivation. The samples were electrophoresed in 12.5% SDS-PAGE under reducing conditions, electrobiotted onto nitrocellu-
lose paper, and probed with a rabbit intiserum monospecific for human fibrinogen. The control lane was from a 16 hour incubate of
fibrinogen without egg homogenate.
Panel C: Fibrinogen solution (10 mg/ml) was incubated with an equal volume of human plasmin (2.5 U/ml) under the same conditions
as for incubation with egg homogenate.
this could be that the thrombogenic potential of the underwent a similar pattern of degradation (Fig. 3,
egg surface is counterbalanced by secretion of fibri- panel C). Enzymes in S. mansoni eggs act similarly
nolytic enzymes. against fibrin as against fibrinogen (Curtis, unpub-
Figure 3, panel A illustrates the presence of en- lished), but it has not yet been established that it is
zymes in S. mansoni eggs which can degrade fibri- the same enzyme which is active against both sub-
nogen in sodium dodecyl sulphate polyacrylamide strates.
gel electrophoresis (SDS-PAGE), the Mr range of The function of these proteases could be to con-
these proteases being between 22 kDa and 50 kDa. trol the level of fibrin deposition around parasite
Figure 3, panel B, shows that during an incubation eggs while they are intravascular. Comparisons be-
time course the S. mansoni egg enzymes degraded tween the respective fibrinolytic activities of S.
fibrinogen into products that, under reducing con- mansoni eggs and plasmin indicated that 1 mg of
ditions in SDS-PAGE, were initially of apparently crude soluble homogenate of freshly isolated eggs
greater size than the native protein. After incuba- contains approximately the equivalent of 20 units
tion for an hour or longer these large derivatives of plasmin fibrinolytic activity (Modha, unpublish-
disappeared and products of smaller size were gen- ed). An active fibrinolytic system such as this might
erated. Fibrinogen incubated with human plasmin
390
also be involved in egg migration through tissue, as reference to parasites and cancer. J Parasitol [66]: 705-721,
1980.
has been suggested for tumour cells [74].
2. Ashall F: Cancer cells and parasites: two of a kind. Tr
Biochem Sci [I1]: 518-520, 1986.
3. Mitchell GF: A note on concomitant immunity in host-
Conclusions parasite relationships: a successfully transplanted concept
from tumor immunity. Adv Cancer Res (In Press).
4. Rollinson D, Simpson AJG (ed): The biology of schisto-
- Schistosomes and tumour metastases are similar
somes: from genes to latrines. Academic Press, London,
in their dependence on proteolytic enzymes for 1987.
migration, survival and growth. 5. Wyler DJ (ed): Modern parasite biology: cellular, immun-
- Different proteases are active at different stages ological and molecular aspects. WH Freeman & Co, New
of schistosome infection in the vertebrate host. York, 1990.
6. Stirewalt MA: Schistosoma mansoni: cercariae to schistoso-
- Molecular characterizations of two schistosome
mule. Adv Parasitol [12]: 115-182, 1974.
enzymes, cercarial elastase and adult worm 7. Haas W, Schmidt R: Characterisation of chemical stimuli
cathepsin B, are at an advanced stage. for the penetration of Schistosoma rnansoni cercariae: I.
- The emphasis given to the potential of some Effective substances, host specificity. Zeitschr Parasitenk
schistosome proteases as aids in immunodiagno- [66]: 293-307, 1982.
8. Wilson RA: Cercariae to liver worms: development and
sis or as candidate vaccines is a reflection of
migration in the mammalian host. In: Rollinson D, Simp-
current trends in parasitological research, and son AJG (ed) The biology of schistosomes: from genes to
of the belief that immunological intervention latrines. Academic Press, London, 1987, pp 115-146.
will be a critical factor in control of diseases like 9. Wheater PR, Wilson, RA: Schistosoma mansoni: a hist-
this one. ological study of migration in the laboratory mouse. Para-
sitology [79]: 49--62, 1979.
10. Wilson RA, Lawson JR: An examination of the skin phase
of schistosome migration using a hamster cheek pouch
Key unanswered question preparation. Parasitology [80]: 257-266, 1980.
11. Landsperger WJ, Stirewalt M, Dresden MH: Purification
Do proteases such as the cercarial elastase facil- and properties of a proteolytic enzyme from the cercariae of
the human trematode Schistosoma mansoni. J Biochem
itate parasite migration solely through their
[201]: 137-144, 1982.
ability to hydrolyse the extracellular matrix; or 12. McKerrow JH, Pino-Heiss S, Lindquist R, Werb Z: Puri-
are other consequences of their action (e.g., fication and characterization of an elastinolytic proteinase
interaction with complement components and secreted by cercariae of Schistosoma mansoni. J Biol Chem
the blood coagulation cascade, and with pro- [260]: 3703-3707, 1985.
13. Tzeng S, McKerrow JH, Fukuyama K, Epstein WL: Degra-
tease inhibitors) also of some significance in
dation of purified skin keratin by a protease secreted from
modeling their migration pathway? Schistosoma mansoni cercariae. J Parasitol [69]: 992-994,
1983.
14. McKerrow JH, Jones P, Sage H, Pino-Heiss S: Proteinases
Acknowledgements
from invasive larvae of the trematode parasite Schistosoma
mansoni degrade connective-tissue and basement-mem-
brane macromolecules. Biochem J [231]: 47-51, 1985.
The authors' work was supported by The Well- 15. Dresden MH: Proteolytic enzymes of Schistosoma manso-
come Trust and the British Medical Research ni. Acta Leidensia [49]: 81-99, 1982.
Council. We are grateful to Ms Andrea Darlow and 16. Newport GR, McKerrow JH, Hedstrom R, Petitt M,
Dr Gordon Cook for permission to use Fig. 1. McGarrigle L, Barr P J, Agabian N: Cloning of the protease
that facilitates infection by schistosome parasites. J Biol
Chem [263]: 13179-13184, 1988.
17. Toy L, Pettit M, Wang YF, Hedstrom R, McKerrow JH:
References The immune response to stage-specific proteolytic enzymes
of Schistosoma mansoni. In: Agabian N, Goddman H, No-
1. Davies AJS, Hall JG, Targett GAT, Murray, M: The bi- gueira N (eds) Molecular paradigms for eradicating helmin-
ological significance of the immune response with special thic parasites. Alan R Liss Inc, New York, 1987, pp 85-103.
391
18. Keene WE, Jeong KH, McKerrow JH, Werb Z: Degrada- 35. Pino-Heiss S, Petitt M, Beckstead JH, McKerrow JH:
tion of extracellular matrix by larvae of Schistosoma manso- Preparation of mouse monoclonal antibodies and evidence
ni. II. Degradation by newly transformed and developing for a host immune response to the preacetabular gland
schistosomula. Lab Invest [49]: 201-207, 1983. proteinase of Schistosoma rnansoni cercariae. Amer J Trop
19. Crabtree JE, Wilson RA: Schistosoma mansoni: an ultra- Med Hyg [35]: 536-543, 1986.
structural examination of skin migration in the hamster 36. Auriault C, Joseph M, Tartar A, Bout D, Tonnel AB,
cheek pouch. Parasitology [91]: 111-120, 1985. Capron A: Regulatory role of a tripeptide (TPK) from the
20. Marikovsky M, Fishelson ZS, Arnon R: Purification and second constant domain ofimmunoglobulin G. I. Inhibition
characterization of proteases secreted by transforming of rat and human macrophage activities. Int J Immuno-
schistosomuta of Schistosoma mansoni. Mol Biochem Para- pharm [7]: 73-79, 1985.
sitol [30]: 45-54, 1988. 37~ Verwaerde C, Auriault C, Damonville M, Neyrinck JL,
21. Auriault C, Ouaissi MA, Torpier G, Eisen H, Capron A: Vendeville C, Capron A: Role of serine proteases of Schis-
Proteolytic cleavage of IgG bound to the Fc receptor of tosoma mansoni in the regulation of IgE synthesis. Scand J
Schistosoma mansoni schistosomula. Parasite Immunol [3]: Immunol [24]: 509-516, 1986.
33--44, 1981. 38. NgaizaJR: PhD Dissertation, University of London, 1988.
22. McKerrow JH, Doenhoff MJ: Schistosome proteases. 39. Miller P, Wilson RA: Migration of the schistosomula of
Parasitol Today [4]: 334-340, 1988. Schistosoma mansoni from the lungs to the hepatic portal
23. Troll W, Frenkel K, Wiesner R: Protease inhibitors: pos- system. Parasitology [80]: 267-288, 1980.
sible preventive agents of various types of cancer and their 40. Crabtree JE, Wilson RA: Schistosoma rnansoni: an ultra-
mechanisms of action. In: Current Concepts and Ap- structural examination of pulmonary migration. Parasit-
proaches to the Study of Prostate Cancer. Alan R. Liss Inc, ology [92]: 343--354, 1986.
New York, 1987, pp 297-315. 41. Coulson PS, Wilson RA: Examination of the mechanisms
24. Cherfas J: New weapon in the war against schistosomiasis. of pulmonary phase resistance to Schistosoma mansoni in
Science [246]: 1242-1243, 1990. vaccinated mice. Amer J Trop Med Hyg [38]: 529-539,
25. Fishelson Z: Complement and parasitic trematodes. Para- 1988.
sitoi Today [5]: 19-25, 1989. 42. Flisser A, McLaren DJ: Effect of praziquantel treatment on
26. Samuelson JC, Caulfield JP: The cercarial glycocalyx of lung-stage larvae of Schistosoma mansoni in vivo. Parasit-
Schistosoma rnansoni. J Cell Biol [100]: 1423-1434, 1985. ology [98]: 203-211, 1989.
27. Marikovsky M, Arnon R, Fishelson Z: Proteases secreted 43. Timms AR, Bueding E: Studies of a proteolytic enzyme
by transforming schistosomula of Schistosoma mansoni from Schistosoma mansoni. Brit J Pharmacol [14]: 68-73,
promote resistance to killing by complememt. J Immunol 1959.
[141]: 273-278, 1988. 44. Klinkert M-Q, Felleisen R, Link G, Ruppel A, Beck E:
28. Bloch EH: In vivo microscopy of schistosomiasis. IV. The Primary structures of Sm31/32 diagnostic proteins of Schis-
dynamics of the host-parasite response to Schistosoma man- tosoma mansoni and their identification as proteases. Mol
soni in the hypodermal tissues as observed in transparent Biochem Parasitol [33]: 113-122, 1989.
chambers in two susceptible hosts during primary and chal- 45. Davis AH, Nanduri J, Watson DC: Cloning and gene ex-
lenge infections. Amer J Trop Med Hyg [33]: 899-910, pression of Schistosoma mansoni protease. J Biol Chem
1984. [262] 12851-12855, 1987.
29. Ruppel A, Rother U, Diesfeld HJ: Schistosoma rnansoni: 46. Felleisen R, Klinkert M-Q: In vitro translation and proces-
development of primary infection in mice genetically defi- sing of cathepsin B of Schistosoma mansoni. EMBO J [9]:
cient or intact in the fifth component of complement. Para- 371-377, 1990.
sitology [85]: 315-323, 1982. 47. Senti AW, Weltman JK, Goldgraber MB, Egyud LG,
30. Harrison RA, Doenhoff MJ: Retarded development of Kuntz RE: Species specificityof the immediate hypersensi-
Schistosoma mansoni in immunosuppressed mice. Parasit- tivity to schistosomal proteolytic enzyme. Parasite Immu-
ology [86]: 4329--438, 1983. nol [1] 79-89, 1979.
31. Fusco AC, Salafsky B, Kevin MB: Schistosoma mansoni: 48. Idris MA, Ruppel A: Diagnostic Mr 31/32000 Schistosoma
eicosanoid production by cercariae. Exp Parasitol [59]: 44- mansoni proteins (Sm31/32): reaction with sera from Suda-
50, 1985. nese patients infected with S. mansoni or S. haematobium. J
32. Asch HA, Dresden MH: Schistosoma mansoni: inhibition Helminthol [62]: 95-101, 1988.
of cercarial 'penetration' proteases by components of mam- 49. Cesari IM, Rodriguez M, McLaren D: Proteolytic enzymes
malian blood. Comp Biochem Physiol [58B]: 89-95, 1977. in adult male and female Schistosoma mansoni. Acta Cien-
33. Modha JA, PhD Dissertation, University of London, 1988. tif Venezolana [32]: 324--329,1981.
34. Banda MJ, Rice AG, Griffin GL, Senior RM: The inhib- 50. Bogitsh BJ, Dresden MH: Fluorescent histochemistry of
itory complex of human alpha 1-proteinase inhibitor and acid proteases in adult Schistosorna rnansoni and Schistoso-
human elastase is a neutrophil chemoattractant. J Exp Med ma japonicum. J Parasitol [69]: 106-110, 1983.
[167]: 1608--1615,1988. 51. Doenhoff MJ, Modha J, Curtis RHC, Adeoye GO: Im-
392
munological identification of Schistosoma mansoni pepti- Platelet-tumor interactions in mice. The role of platelets in
dases. Mol Biochem Parasitol [31]: 233-240, 1988. the spread of malignant disease. Int J Cancer [11]: 704-718,
52. Warren KS, The pathogenesis of 'clay pipe-stem cirrhosis' 1973.
in mice with chronic schistosomiasis mansoni, with a note 68. Fidler IJ, Gersten DM, Kripke ML: Influence of immune
on the longevity of schistosomes. Amer J Path [49]: 477- status on the metastasis of three murine fibrosarcomas of
489, 1966. different immunogenicities. Cancer Res [39]: 3816-3821,
53. Warren KS, Mahmoud AA, Cummings P, Murphy DJ, 1979.
Houser HB: Schistosomiasis mansoni in Yemeni in Cali- 69. Karpatkin S, Pearlstein E: Role of platelets in tumour cell
fornia: duration of infection, presence of disease, ther- metastasis. Ann Int Med [95]: 636-641, 1981.
apeutic management. Amer J Trop Med Hyg [23]: 902-909, 70. Gasic GJ, Tuszynski GP, Gorelik E: Interaction of the
1974. haemostatic and immune systems in the metastatic spread
54. Pearce EJ, Sher A: Mechanisms of immune evasion in of tumour cells. Int Rev Exp Pathol [29]: 173-212, 1986.
schistosomiasis. Contr Microbiol Immunol [8]: 219-232, 71. Doenhoff MJ, Pearson S, Dunne DW, Bickle Q, Lucas S,
1987. Bain J, Musallam R, Hassounah O: Immunological control
55. Damian RT, Greene ND, Hubbard WJ: Occurrence of of hepatotoxicity and parasite egg excretion in Schistosoma
mouse alpha-2-macroglobulin antigenic determinants on S. mansoni infection: stage-specificity of the reactivity of im-
mansoni adults, with evidence on their nature. J Parasitol mune serum in T-cell deprived mice. Trans Roy Soc Trop
[59]: 64--73, 1973. Med Hyg [75]: 41-53, (1981).
56. James K: Interactions between cytokines and alpha 2-mac- 72. Dunne DW, Hassounah O, Musallam R, Lucas S, Pepys
roglobulin. Immunol Today [11]: 163-166, 1990. MB, Baltz M, Doenhoff M: Mechanisms of Schistosoma
57. Modha J, Parikh V, Gauldie J, Doenhoff MJ: An associ- rnansoni egg excretion: parasitological observations in im-
ation between sehistosomes and contrapsin, a mouse serine munosuppressed mice reconstituted with immune serum.
protease inhibitor (serpin). Parasitology [96]: 99-109,1988. Parasite Immunol [5]: 47-60, 1983.
58. Hill RE, Hastie ND: Accelerated evolution in the reactive 73. Weitz JI, Huang AJ, Landman SL, Nicholson AC, Silver-
centre regions of serine protease inhibitors. Nature [326]: stein SC: Elastase-mediated fibrinogenolysis by chemo-
96--99, 1987. attractant-stimulated neutrophils occurs in the presence of
59. Kloetzel K: A collagenaselike substance produced by eggs physiologic concentrations of antiproteases. J Exp Med
of Schistosoma mansoni. J Parasitol [54]: 177-178, 1968. [166]: 1836-1850, 1987).
60. Asch HL, Dresden MH: Acidic thiol proteinase activity of 74. Dano K, Andreason PA, Gr0ndahl-Hansen J, Kristensen
Schistosoma mansoni egg extracts. J Parasitol [65]: 543- P, Nielsen LS, Skriver L: Plasminogen Activators, Tissue
549, 1979. Degradation and Cancer. Adv Cancer Res [44]: 139-266,
61. Xu Y-Z, Shawar SM, Dresden MH: Schistosoma mansoni: 1985).
purification and characterization of a membrane-associated 75. Fracker PJ, Speck JC: Protein and cell membrane iod-
leucine aminopeptidase. Exp Parasitol [70]: 124-133, 1990. ination with a sparingly soluble choroamide 1, 3, 4, 6-
62. Xu Y-Z, Dresden MH: Leucine aminopeptidase and hatch- tetrachloro-3 alpha, 6 alpha-diphenylglycouryl. Biochem
ing of Schistosoma mansoni eggs. J. Parasitol [72]: 507-511, Biophys Res Comm [80]: 849-857, 1978.
1986. 76. Tamashiro WK, Rao M, Scott A: Proteolytic cleavage of
63. NgaizaJR, DoenhoffMJ: Blood platelets and schistosome IgG and other protein substrates by Dirofilaria immitis
egg excretion. Proc Soc Exp Biol Med [193]: 73-79, 1990. microfilarial enzymes. J Parasitol [73]: 149-154, 1987.
64. Doenhoff MJ, Hassounah OA, Lucas SB: Does immuno- 77. Lockwood BC, North MJ, Scott KI, Bremner AF, Coombs
pathology induced by schistosome eggs potentiate parasite GH: The use of highly sensitive electrophoretic method to
survival. Immunol Today [6]: 203--206, 1985. compare the proteinases of trichomonads. Mol Biochem
65. Doenhoff MJ, Hassounah O, Murare H, Lucas S: The Parasitol [24]: 89-95, 1987.
schistosome egg granuloma: immunopathology in the cause
of host protection or parasite survival? Trans Roy Soc Trop Address for offprints:
Med Hyg [80]: 503-514, 1986. M.J. Doenhoff,
66. Damian RT: The exploitation of host immune responses by School of Biological Sciences,
parasites. J Parasitol. [73]: 1-13, 1987. University College of North Wales,
67. Gasic GJ, Gasic TB, Galanti N, Johnson T, Murphy S: Bangor, Gwynedd, LL57 2UW, UK